https://www.selleckchem.com/products/yo-01027.html
Context Inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn disease, are chronic relapsing inflammatory diseases that affect 1.5 million people in the United States. Lymphatic pump treatment (LPT) techniques were designed to enhance the movement of lymph and can be used to relieve symptoms in patients with IBD and other gastrointestinal disorders. Objective To determine whether LPT would decrease gastrointestinal inflammation and reduce disease severity in rats with acute IBD. Methods On day 0, rats were randomized i
إعجاب
علق
شارك
